WUXI BIOLOGICS Valuation
| 1FW1 Stock | EUR 4.18 0.08 1.95% |
At this time, the company appears to be overvalued. WUXI BIOLOGICS UNSPADR2 maintains a prevalent Real Value of €3.55 per share. The last-minute price of the company is €4.18. Our model calculates the value of WUXI BIOLOGICS UNSPADR2 from examining the company fundamentals such as Return On Asset of 0.0551, shares outstanding of 2.11 B, and Profit Margin of 0.31 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that WUXI BIOLOGICS's price fluctuation is very risky at this time. Calculation of the real value of WUXI BIOLOGICS UNSPADR2 is based on 3 months time horizon. Increasing WUXI BIOLOGICS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the WUXI stock is determined by what a typical buyer is willing to pay for full or partial control of WUXI BIOLOGICS UNSPADR2. Since WUXI BIOLOGICS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of WUXI Stock. However, WUXI BIOLOGICS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.18 | Real 3.55 | Hype 4.18 | Naive 4.12 |
The real value of WUXI Stock, also known as its intrinsic value, is the underlying worth of WUXI BIOLOGICS UNSPADR2 Company, which is reflected in its stock price. It is based on WUXI BIOLOGICS's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of WUXI BIOLOGICS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of WUXI BIOLOGICS UNSPADR2 helps investors to forecast how WUXI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of WUXI BIOLOGICS more accurately as focusing exclusively on WUXI BIOLOGICS's fundamentals will not take into account other important factors: WUXI BIOLOGICS Total Value Analysis
WUXI BIOLOGICS UNSPADR2 is presently anticipated to have takeover price of 0 with market capitalization of 32.39 B, debt of 3.33 B, and cash on hands of 8.48 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the WUXI BIOLOGICS fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 32.39 B | 3.33 B | 8.48 B |
WUXI BIOLOGICS Investor Information
The company has Price/Earnings (P/E) ratio of 238.12. WUXI BIOLOGICS UNSPADR2 had not issued any dividends in recent years. Based on the key indicators related to WUXI BIOLOGICS's liquidity, profitability, solvency, and operating efficiency, WUXI BIOLOGICS UNSPADR2 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.WUXI BIOLOGICS Asset Utilization
One of the ways to look at asset utilization of WUXI is to check how much profit was generated for every dollar of assets it reports. WUXI BIOLOGICS UNSPADR2 harnesses its resources almost 0.0551 (%), securing 0.0551 cents for each euro of resources held by the company. An expanding asset utilization attests that the company is being more effective with each euro of resources it maintains. Specifically, asset utilization of WUXI BIOLOGICS shows how effective it operates for each euro spent on its resources.WUXI BIOLOGICS Ownership Allocation
WUXI BIOLOGICS UNSPADR2 retains a total of 2.11 Billion outstanding shares. Roughly 99.99 (%) of WUXI BIOLOGICS outstanding shares are held by general public with 0.007 percent by institutional investors. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.WUXI BIOLOGICS Profitability Analysis
The company reported the revenue of 13.09 B. Net Income was 1.69 B with profit before overhead, payroll, taxes, and interest of 4.83 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates WUXI BIOLOGICS's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in WUXI BIOLOGICS and how it compares across the competition.
About WUXI BIOLOGICS Valuation
The stock valuation mechanism determines WUXI BIOLOGICS's current worth on a weekly basis. Our valuation model uses a comparative analysis of WUXI BIOLOGICS. We calculate exposure to WUXI BIOLOGICS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of WUXI BIOLOGICS's related companies.WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. WuXi Biologics Inc. is a subsidiary of WuXi Biologics Holdings Limited. WUXI BIOLOGICS is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct WUXI BIOLOGICS's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates WUXI BIOLOGICS's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct WUXI BIOLOGICS's valuation analysis, follow these 8 steps:- Gather financial information: Obtain WUXI BIOLOGICS's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine WUXI BIOLOGICS's revenue streams: Identify WUXI BIOLOGICS's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research WUXI BIOLOGICS's industry and market trends, including the size of the market, growth rate, and competition.
- Establish WUXI BIOLOGICS's growth potential: Evaluate WUXI BIOLOGICS's management, business model, and growth potential.
- Determine WUXI BIOLOGICS's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate WUXI BIOLOGICS's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for WUXI Stock analysis
When running WUXI BIOLOGICS's price analysis, check to measure WUXI BIOLOGICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WUXI BIOLOGICS is operating at the current time. Most of WUXI BIOLOGICS's value examination focuses on studying past and present price action to predict the probability of WUXI BIOLOGICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WUXI BIOLOGICS's price. Additionally, you may evaluate how the addition of WUXI BIOLOGICS to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |